Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2015 (2015), Article ID 274892, 5 pages
http://dx.doi.org/10.1155/2015/274892
Research Article

Impact of Admission Glycosylated Hemoglobin A1c on Angiographic Characteristics and Short Term Clinical Outcomes of Nondiabetic Patients with Acute ST-Segment Elevation Myocardial Infarction

1Cardiology Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt
2Internal Medicine Department, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt
3Medical Biochemistry Department, Faculty of Medicine, Al-Azhar University, Cairo 11651, Egypt

Received 23 June 2015; Revised 10 October 2015; Accepted 16 November 2015

Academic Editor: Terrence D. Ruddy

Copyright © 2015 Islam El-sherbiny et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Aguilar, S. D. Solomon, L. Koøber et al., “Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the Valsartan in acute myocardial infarction (VALIANT) trial,” Circulation, vol. 110, no. 12, pp. 1572–1578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Ishihara, S. Kojima, T. Sakamoto et al., “Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era,” American Heart Journal, vol. 150, no. 4, pp. 814–820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Ishihara, “Acute hyperglycemia in patients with acute myocardial infarction,” Circulation Journal, vol. 76, no. 3, pp. 563–571, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Planer, B. Witzenbichler, G. Guagliumi et al., “Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial,” International Journal of Cardiology, vol. 167, no. 6, pp. 2572–2579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Koraćević, S. Petrović, M. Tomašević, S. Apostolović, and M. Damjanović, “Stress hyperglycemia in acute myocardial infaraction,” Facta Universitatis Series: Medicine and Biology, vol. 13, no. 3, pp. 152–157, 2006. View at Google Scholar
  6. K. H. Gabbay, K. Hasty, J. L. Breslow, R. C. Ellison, H. F. Bunn, and P. M. Gallop, “Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus,” Journal of Clinical Endocrinology and Metabolism, vol. 44, no. 5, pp. 859–864, 1977. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Naito, K. Miyauchi, M. Ogita et al., “Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome,” Journal of Cardiology, vol. 63, no. 2, pp. 106–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Knowles, W. Haigh, G. Michaud, and V. Marchesi, “A monoclonal antibody—based immunoassay for HbA1c,” Diabetes, vol. 35, supplement 94A, 1986. View at Google Scholar
  9. R. R. Little, C. L. Rohlfing, H. M. Wiedmeyer, G. L. Myers, D. B. Sacks, and D. E. Goldstein, “NGSP Steering Comittee: the national glycohemoglobin standardization program: a five-year progress report,” Clinical Chemistry, vol. 47, no. 11, pp. 1985–1992, 2001. View at Google Scholar
  10. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010. View at Publisher · View at Google Scholar
  11. J. S. Hochman, G. A. Lamas, C. E. Buller et al., “Coronary intervention for persistent occlusion after myocardial infarction,” The New England Journal of Medicine, vol. 355, no. 23, pp. 2395–2407, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Cohen, J. E. Diez, G. N. Levine et al., “Pharmacoinvasive management of acute coronary syndrome: incorporating the,” Journal of Invasive Cardiology, vol. 19, no. 12, pp. 525–540, 2007. View at Google Scholar
  13. W. Wijns, P. Kolh, N. Danchin et al., “Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI),” European Heart Journal, vol. 31, no. 20, pp. 2501–2555, 2010. View at Google Scholar
  14. T. J. Ryan, D. P. Faxon, R. M. Gunnar et al., “Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty),” Circulation, vol. 78, no. 2, pp. 486–502, 1988. View at Google Scholar
  15. F. D'Ascenzo, G. Biondi-Zoccai, C. Moretti et al., “TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients,” Contemporary Clinical Trials, vol. 33, no. 3, pp. 507–514, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Cakmak, N. Cakmak, S. Cetemen et al., “The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction,” Canadian Journal of Cardiology, vol. 24, no. 5, pp. 375–378, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. E. Kassaian, H. Goodarzynejad, M. A. Boroumand et al., “Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting,” Cardiovascular Diabetology, vol. 11, article 82, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Prasad, P. Bekker, and S. Tsimikas, “Advanced glycation end products and diabetic cardiovascular disease,” Cardiology in Review, vol. 20, no. 4, pp. 177–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Ashraf, M. A. Boroumand, A. Amirzadegan, S. A. Talesh, and G. Davoodi, “Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity,” Diabetes Research and Clinical Practice, vol. 102, no. 3, pp. 225–232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. G. Ertem, H. Bağbancı, H. Kılıç, E. Yeter, and R. Akdemir, “Relationship between HbA1c levels and coronary artery severity in nondiabetic acute coronary syndrome patients,” Türk Kardiyoloji Derneği Arşivi, vol. 41, no. 5, pp. 389–395, 2013. View at Publisher · View at Google Scholar · View at Scopus